OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+25.54%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.29%
AUM
$135M
AUM Growth
+$135M
(+6.3%)
Cap. Flow
+$13.8M
Cap. Flow
% of AUM
10.23%
Top 10 Holdings %
Top 10 Hldgs %
69.24%
Holding
34
New
11
Increased
9
Reduced
7
Closed
4
Top Buys
| 1 |
Travere Therapeutics
TVTX
|
$24.4M |
| 2 |
CMRX
Chimerix, Inc.
CMRX
|
$12.2M |
| 3 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$4.32M |
| 4 |
BIND
BIND THERAPEUTICS INC
BIND
|
$3.25M |
| 5 |
InspireMD
NSPR
|
$3.1M |
Top Sells
| 1 |
GENT
GENTIUM SPA ADS
GENT
|
$29.2M |
| 2 |
Ligand Pharmaceuticals
LGND
|
$3.7M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$3.64M |
| 4 |
Geron
GERN
|
$3.22M |
| 5 |
Nuwellis
NUWE
|
$2.13M |
Sector Composition
| 1 | Healthcare | 72.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPXX
26
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
| $1.03M | 0.76% | 325,000 +15,000 | +5% | +$47.6K |
|
27
MacroGenics
MGNX
$112M
| $838K | 0.62% | +30,000 | New | +$838K |
|
|
AFFX
28
DELISTED
AFFYMETRIX INC
AFFX
| $713K | 0.53% | +100,000 | New | +$713K |
|
|
KIPS
29
DELISTED
KIPS BAY MEDICAL INC
KIPS
| $540K | 0.4% | +777,531 | New | +$540K |
|
|
30
Nuwellis
NUWE
$4.6M
| $350K | 0.26% | 60,000 -365,100 | -86% | -$2.13M |
|
|
ICPT
31
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – | -56,900 | Closed | -$3.64M |
|
|
INFI
32
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| – | – | -130,000 | Closed | -$1.67M |
|
|
GENT
33
DELISTED
GENTIUM SPA ADS
GENT
| – | – | -505,000 | Closed | -$29.2M |
|
|
MDVN
34
DELISTED
MEDIVATION, INC.
MDVN
| – | – | -25,000 | Closed | -$1.6M |
|